Announcements

Updates on campus events, policies, construction and more.

close  

Information for Our Community

Whether you are part of our community or are interested in joining us, we welcome you to Washington University School of Medicine.

close  


Visit the News Hub

Fiber from crustaceans, insects, mushrooms promotes digestion

Findings, in mice, suggest engaging immune system with such fiber to counteract obesity

by Marta WegorzewskaSeptember 7, 2023

Getty Images

Who can forget the stomach-churning moments when “Survivor” contestants forced down crunchy insects, among other unappetizing edibles, for a chance to win $1 million? In daring culinary challenges, the TV show’s contestants exhibited gastronomic bravery as viewers watched in discomfort.

Digesting a crunchy critter starts with the audible grinding of its rigid protective covering — the exoskeleton. Unpalatable as it may sound, the hard cover might be good for the metabolism, according to a new study, in mice, from Washington University School of Medicine in St. Louis.

The researchers, led by Steven Van Dyken, PhD, an assistant professor of pathology & immunology, found in mice that digesting chitin, an abundant dietary fiber in insect exoskeletons and also mushrooms and crustacean shells, engages the immune system. An active immune response was linked to less weight gain, reduced body fat and a resistance to obesity.

“Obesity is an epidemic,” Van Dyken said. “What we put into our bodies has a profound effect on our physiology and on how we metabolize food. We’re investigating ways to counteract obesity based on what we learn about how the immune system is engaged by diet.”

The study is published Sept. 7 in Science.

The immune system is well known for safeguarding the body against various threats, including bacteria, viruses, allergens and even cancer. The researchers found that a particular arm of the immune system also is involved in chitin digestion. Stomach distention after chitin ingestion activates an innate immune response that triggers stomach cells to ramp up production of enzymes, known as chitinases, that break down chitin. Of note, chitin is insoluble — incapable of being dissolved in liquid — and thus requires enzymes and harsh acidic conditions to digest.

Do-Hyun Kim, PhD, a postdoctoral research associate and first author on the study, performed the experiments in germ-free mice lacking intestinal bacteria. His results show that chitin activates immune responses in the absence of bacteria.

“We think chitin digestion mainly relies on the host’s own chitinases,” Van Dyken said. “The stomach cells change their enzymatic output through a process we refer to as adaptation. But it is surprising that this process is happening without microbial input, because bacteria in the gastrointestinal tract are also sources of chitinases that degrade chitin.” Van Dyken noted that in mice with intestinal bacteria, dietary chitin altered the bacterial composition in the lower gastrointestinal tract, suggesting that gut bacteria also adapt to chitin-containing food after it leaves the stomach.

The research team found that the greatest impact on obesity in mice occurred when chitin activated the immune system but was not digested. Mice fed a high-fat diet also were given chitin. Some mice lacked the ability to produce chitinases to break down chitin. The mice that ate chitin but couldn’t break it down gained the least amount of weight, had the lowest body fat measurements and resisted obesity, compared with mice that didn’t eat chitin and with those that did but could break it down.

If the mice could break down chitin, they still benefited metabolically, but they adapted by overproducing chitinases to extract nutrients from chitin.

Van Dyken and his team next plan to follow up on their findings in people, with a goal of determining whether chitin could be added to human diets to help control obesity.

“We have several ways to inhibit stomach chitinases,” he said. “Pairing those approaches with a chitin-containing food might have a very real metabolic benefit.”

Kim D.-H, Wang Y, Jung H, Field RL, Zhang X, Liu T.-C, Ma C, Fraser JS, Brestoff JR, & Van Dyken SJ. A type 2 immune circuit in the stomach controls mammalian adaptation to dietary chitin. Science. Sept. 7, 2023. DOI: 10.1126/science.add5649

Funding for this project was provided in part by the Bursky Center for Human Immunology and Immunotherapy Programs at Washington University; the Washington University Center for Cellular Imaging (WUCCI) supported by Washington University School of Medicine; the Children’s Discovery Institute of Washington University and St. Louis Children’s Hospital, grant numbers CDI-CORE-2015-505, CDI-CORE-2019-813; The Foundation for Barnes-Jewish Hospital, grant numbers 3770, 4642; and the Washington University Rheumatic Diseases Research Resource-Based Center funded by the National Institutes of Health (NIH), grant number P30 AR073752; the NIH, grant numbers DP5 OD028125, R01HL148033, R01AI176660, R21AI163640; Burroughs Wellcome Fund, grant number CAMS 1019648; and the National Research Foundation of Korea Award, grant number NRF-2020R1A6A3A03037855.

About Washington University School of Medicine

WashU Medicine is a global leader in academic medicine, including biomedical research, patient care and educational programs with 2,800 faculty. Its National Institutes of Health (NIH) research funding portfolio is the third largest among U.S. medical schools, has grown 52% in the last six years, and, together with institutional investment, WashU Medicine commits well over $1 billion annually to basic and clinical research innovation and training. Its faculty practice is consistently within the top five in the country, with more than 1,800 faculty physicians practicing at 65 locations and who are also the medical staffs of Barnes-Jewish and St. Louis Children’s hospitals of BJC HealthCare. WashU Medicine has a storied history in MD/PhD training, recently dedicated $100 million to scholarships and curriculum renewal for its medical students, and is home to top-notch training programs in every medical subspecialty as well as physical therapy, occupational therapy, and audiology and communications sciences.

Marta covers pathology & immunology, cell biology & physiology, pediatrics, radiology, gastroenterology, rheumatology, and technology management, among other topics. She holds a bachelor's degree in biology from Georgetown University and a PhD in immunology from the University of California, San Francisco. She did her postdoctoral work in Washington University’s Department of Pathology & Immunology. Marta joined WashU Medicine Marketing & Communications in 2023 after working as a science writer in the Department of Biology on the Danforth Campus for five years.